Delanzomib

CEP-18770 is an orally active inhibitor of the chymotrypsin-like activity of proteasome (IC50: 3.8 nM). It only marginally inhibits the tryptic and peptidylglutamyl activities of the proteosome.

Price Not Available 25 mg Delanzomib Supplier Page

Catalog Number	T6027
Alternative Name(s)	CEP-18770
Research Area	NF-Κb\|\|\|Ubiquitination\|\|\|Proteases/Proteasome\|\|\|Apoptosis
Molecular Formula	C21H28BN3O5
CAS#	847499-27-8
Purity	99.46%
SMILES	B([C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)c1cccc(n1)c1ccccc1)(O)O
Size	25 mg
Supplier Page	https://www.targetmol.com/compound/Delanzomib
Additional Information	https://www.targetmol.com/datasheet/T6027